Understanding CIPC: A Potential Drug Target (G85457)

Target Name: CIPC

NCBI ID: G85457

CIPC

Understanding CIPC: A Potential Drug Target

CIPC (CIPC\\_HUMAN), a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and muscle, has been identified as a potential drug target or biomarker. Its unique structure and function have made it an attractive target for scientists to study.

CIPC is a transmembrane protein that is composed of two distinct domains: a N-terminal transmembrane domain and a C-terminal cytoplasmic domain. The N-terminal transmembrane domain is responsible for the protein's ability to interact with various cell surface receptors, while the C-terminal cytoplasmic domain is responsible for the protein's ability to interact with intracellular molecules.

One of the most significant features of CIPC is its role in the regulation of cellular processes that are critical for life. For example, CIPC has been shown to be involved in the regulation of cell division, cell growth, and apoptosis. Additionally, CIPC has been shown to play a role in the regulation of ion channels, which are responsible for the flow of electrical current through the cell membrane.

CIPC has also been shown to be involved in the regulation of signaling pathways that are important for various cellular processes. For example, CIPC has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cellular processes such as cell growth, differentiation, and survival.

Given its involvement in so many cellular processes, CIPC has been identified as a potential drug target. The development of compounds that can specifically target CIPC and modulate its activity could be a valuable tool for the treatment of various diseases.

One of the challenges in studying CIPC is its complex structure and function. To fully understand the mechanisms of CIPC's activity, scientists need to be able to study its activity in detail. This can be achieved through various techniques, such as biochemical assays, cell-based assays, and in vitro studies.

To begin, scientists can use biochemical assays to study the activity of CIPC. These assays can be used to determine the presence and activity of specific proteins or to study the effects of drugs on CIPC's activity. For example, scientists can use biochemical assays to determine the levels of CIPC in cells and to study the effects of drugs on its levels.

Scientists can also use cell-based assays to study the activity of CIPC. These assays involve the use of live cells, such as neurons or cancer cells, to study the effects of drugs on CIPC's activity. For example, scientists can use cell-based assays to study the effects of drugs on the growth, migration, and survival of cancer cells.

In vitro studies can also be used to study the activity of CIPC. These studies are conducted in a controlled environment, such as a laboratory setting, and involve the use of in vitro cell culture systems. For example, scientists can use in vitro studies to study the effects of drugs on the activity of CIPC in cell culture models of diseases, such as cancer.

Overall, the study of CIPC is an exciting and promising area of research. With the development of new technologies and the efforts of scientists, it is likely that the mechanisms of CIPC's activity will be fully understood and its potential as a drug target will be realized.

Protein Name: CLOCK Interacting Pacemaker

Functions: Transcriptional repressor which may act as a negative-feedback regulator of CLOCK-BMAL1 transcriptional activity in the circadian-clock mechanism. May stimulate BMAL1-dependent phosphorylation of CLOCK. However, the physiogical relevance of these observations is unsure, since experiments in an animal model showed that CIPC is not critially required for basic circadian clock

The "CIPC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CIPC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets